Ancell anti-CD63 antibody used to capture Tumor Extracellular Vesicles from Colorectal Cancer patient plasma in a high throughput deviceBy room34 / November 24, 2021 The device captures EV from plasma and analyzes clinically relevant tumour biomarkers (EGFR, EpCAM, CD24 and GPA33) of colorectal cancer (CRC). The results were predictive of disease severity and prognosis for the test subjects. “An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma” Jongmin Park, Hakho Lee, et al. (June 2021) Nature Biomedical Engineering 5(7): 678-689. doi: 10.1038/s41551-021-00752-7. Epub 2021 Relevant Ancell Products anti-human CD63 anti-human CD24 anti-human CD326 (EpCAM)
